Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.45    0.05 (3.45%)
Bid:
1.40
Ask:
1.50
Spread: 0.10 (7.143%)
Market Cap: £12.93m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Additional Subscription Shares

20 Jun 2024 07:00

RNS Number : 1118T
Xeros Technology Group plc
20 June 2024
 

TERMS NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS GIVEN TO THEM IN THE COMPANY'S ANNOUNCEMENT RELEASED AT 4:40 P.M. ON 4 APRIL 2024.

 

20 June 2024

Xeros Technology Group plc

 

("Xeros", the "Company" or the "Group")

 

Additional Subscription Shares

 

 

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, confirms further to the announcement of its Fundraising on 4 April 2024 (the "Fundraising"), that participants in the Fundraising are entitled to subscribe for Additional Subscription Shares at the Issue Price, in the ratio of one Additional Subscription Share for every two Ordinary Shares subscribed for in the Fundraising. 

 

Investors who participated via the Placing and Subscription will be sent an electronic copy of the exercise notice form ("Exercise Notice") which contains full instructions on how to exercise entitlements and subscribe for the Additional Subscription Shares. Shareholders who participated via the Retail Offer can contact their respective intermediary for copies of the Exercise Notice. Alternatively Exercise Notices can be obtained by written request to ir@xerostech.com. Completed Exercise Notices will be treated as irrevocable, once received by the Company.

 

Terms of the Additional Subscription Shares

 

The arrangements described in this announcement apply to all investors in the Fundraising save for Amati Global Investors Limited whose entitlement for Additional Subscription Shares is set out in a separate Deferred Subscription Deed, as noted in the original Fundraising announcement.

 

As referred to above, the Company has agreed to issue Additional Subscription Shares to investors in the Placing, Subscription and Retail Offer on the basis of one Additional Subscription Share for every two new Ordinary Shares subscribed for. Accordingly, the maximum number of new Ordinary Shares that could be admitted pursuant to the exercise of Additional Subscription Shares is up to 155,394,771 Ordinary Shares. The Additional Subscription Shares are exercisable at the Fundraising Issue Price of 1.5 pence per Ordinary Share during the Additional Subscription Exercise Period.

 

The Company will make the appropriate announcements as and when it issues new Ordinary Shares pursuant to the exercise of Additional Subscription Shares.

 

The other key terms and conditions of the Additional Subscription Shares are set out below:

 

Subscription Rights

Each participant in the April 2024 Fundraising has the right to subscribe for one new Ordinary Share for every two Ordinary Shares subscribed for in the Fundraising, at the Issue Price of 1.5 pence per new Ordinary Share, by notice to the Company during the Exercise Period.

 

Exercise Period

Participants in the Fundraising with entitlements to subscribe for Additional Subscription Shares can exercise these entitlements up until 31 January 2025.

 

Condition to Exercise

Participants with rights to subscribe for Additional Subscription Shares can only do so provided that they, at the time of exercise, still hold at least the number of Ordinary Shares subscribed for in the Fundraising. If their total holding at the time of exercise is below the number of Ordinary Shares subscribed in the Fundraising, they will be limited to exercising a lower number of Additional Subscription Shares on a pro rata basis.

 

Allotment Periods

The Company will allot the new Ordinary Shares pursuant to valid exercises received every two weeks ("Allotment Period"). In order for exercises to be included in any given Allotment Period, they should be completed and with the Company such that they are received by no later than 12 noon on the second Thursday of that Allotment Period. If they are received after this time they will be included in the following Allotment Period. You will be notified if this is the case. The first Allotment Period will run from the date of this announcement until 4 July 2024, and at two-week intervals thereafter, in each case ending at 12 noon on the second Thursday thereafter.

 

Settlement

Unless an Exercise Notice is rejected or deferred to a later Allotment Period (in which case applicants will be informed accordingly by the Company) settlement will take place as follows:

 

a) Trade Time and Date: 0800 on the next following Monday (after the end of the relevant Allotment Period (or next following business day if such day is a Bank Holiday);

 

b) Settlement Date: 2 business days after the Trade Date determined, as per a) above.

Exercise of Additional Subscription Shares

 

Placing and Subscription: The Additional Subscription Shares may be exercised in whole or in part during the Exercise Period by participants in the Placing or Subscription, provided that any partial exercise by a participant shall be for a minimum aggregate exercise price of £5,000 or, if less, the balance of the relevant participants Additional Subscription Shares then outstanding. Completed Exercise Notices will be treated as irrevocable, once received by the Company.

 

Retail Offer: The Additional Subscription Shares may be exercised in whole or in part during the Exercise Period by participants in the Retail Offer, provided that any partial exercise by a participant shall be for a minimum aggregate exercise price of £1,000 or, if less, the balance of the relevant participants Additional Subscription Shares then outstanding. Completed Exercise Notices will be treated as irrevocable, once received by the Company.

 

Adjustment to Subscription Rights  

The subscription rights conferred by the Additional Subscription Shares shall be adjusted by the Board in its sole discretion on the occurrence of certain events in relation to the Company, including

 

a) a subdivision, consolidation or reclassification of the Ordinary Shares;

 

b) a reduction of capital or any other reduction in the number of Ordinary Shares in issue from time to time;

 

c) an issue of Ordinary Shares by way of dividend or distribution or by way of capitalisation of profits or reserves; or

 

d) a consolidation, amalgamation or merger of the Company with or into another entity in certain circumstances,

 

with the intention, in broad terms, that any such adjustment would leave the shareholders with rights to exercise Additional Subscription Shares in a similar position to the position they were in immediately before the event giving rise to the adjustment.

 

Transfer 

Entitlements to Additional Subscription Shares are non-transferable without the prior consent of the Company.

 

Security

The Additional Subscription Shares are not secured.

 

Enquiries

 

Xeros Technology Group plc

Neil Austin, Chief Executive Officer

Alex Tristram, Director of Finance

 

Tel: 0114 269 9656

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

 

Tel: 020 7220 0500

Belvedere Communications

Cat Valentine

Keeley Clarke

xeros@belvederepr.com

Mob: 07715 769 078

Mob: 07967 816 525

 

About Xeros

 

Xeros Technology plc has developed patented and proven, industry-leading technologies which reduce the environmental impact of how industries make and care for clothes.

 

The traditional wet processing methods used in industrial and domestic laundry and garment manufacturing consume billions of litres of fresh water and large amounts of energy and chemicals, as well as damaging and weakening clothing fibres and creating rising levels of environmental pollution. It is estimated that washing machines contribute 35% of the 171 trillion microplastic particles in the ocean.

 

A range of actors, including consumers, the media NGOs and regulators are exerting pressure on these industries, with legislative action beginning to be taken.

 

Xeros' three main technologies, FiltrationFinish, and Care, facilitate garment manufacturers, industrial laundries, domestic washing machine manufacturers and consumers, to reduce their environmental impact, whilst also significantly improving efficiency in the process.

 

Xeros' model is to generate revenue from licensing its technologies, generating royalties and the sale of consumables. Currently there are 8 agreements in place. The addressable markets in Filtration, Finish and Care are estimated to be valued at £350m p.a., £132m p.a. and £3bn p.a. respectively.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEASKNFLFLEFA
Date   Source Headline
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity
13th Feb 202512:05 pmRNSTR-1 Spreadex
13th Feb 202510:21 amRNSTR-1 First Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.